Nursing and Health Professions
Patient
100%
Adverse Event
37%
Drug
31%
Chemoembolization
31%
Imaging
12%
Incidence
12%
Inpatient
12%
Follow up
6%
Logistic Regression Analysis
6%
National Health Organization
6%
Clinical Laboratory
6%
Neoplasm
6%
Nomenclature
6%
Metastasis
6%
Combination Therapy
6%
Doxil
6%
Irinotecan
6%
Minimal Residual Disease
6%
Liver Toxicity
6%
Symptom
6%
Device Material
6%
Analysis
6%
Time
6%
Procedures
6%
Syndrome
6%
Medicine and Dentistry
Adverse Event
37%
Biliary Injury
37%
Liver
37%
Transcatheter Arterial Chemoembolization
31%
Chemotherapeutic Agent
31%
Drug
31%
Incidence
12%
Follow up
6%
Neoplasm
6%
Development
6%
Minimal Residual Disease
6%
Metastatic Carcinoma
6%
Combination Therapy
6%
Logistic Regression Analysis
6%
Hepatocellular Carcinoma
6%
Lesion
6%
Doxorubicin
6%
Irinotecan
6%
Population Research
6%
Liver Toxicity
6%
Predictive Factor
6%
Predictor
6%
Symptom
6%
Analysis
6%
Assessment
6%
Cancer
6%
INIS
patients
56%
liver
56%
injuries
37%
drugs
31%
diseases
12%
laboratories
6%
data
6%
cancer
6%
tumors
6%
range
6%
assessments
6%
therapy
6%
populations
6%
safety
6%
toxicity
6%
metastases
6%
malignancies
6%
symptoms
6%
hepatomas
6%
inclusions
6%
doxorubicin
6%
regression analysis
6%